Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you today? A shiny sun is hovering over the Pharmalot corporate campus, where are a cool breeze is wafting through the windows, and birds and bugs are offering a gloriously soothing cacophony of chitter chatter. As for us, we are busy doing the usual - reading documents and lining up interesting conversations. As always, we are helped along by a little cup of stimulation and, of course, we invite you to join us. Meanwhile, here are some tidbits. Have a great day and stay in touch... Dr. Reddy's To Shift Toward More Brand-Name Drugs (Business Standard) Glaxo Credit Outlook Cut To Negative By Moody's (The Telegraph) Merck Profit Tumbles On Charges And Lower Revenue (Associated Press) UK ADHD Guidelines Aim To Improve 'Patchy' Treatment (Bloomberg News) Drugmakers Lobby Congress To Keep Orphan Drug Tax Credit (Financial Times) Patient Taking Novartis Gilenya MS Pill Developed PML (Reuters) California Stem Cell Agency To Allocate $70M For Clinical Trials (Outsourcing Pharma) Indian...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs